616 related articles for article (PubMed ID: 23188583)
1. [Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].
Sener A; Akçalı A; Karatağ O; Koşar S; Değirmenci Y; Akman T
Mikrobiyol Bul; 2012 Oct; 46(4):689-94. PubMed ID: 23188583
[TBL] [Abstract][Full Text] [Related]
2. Rationale for chemotherapy of tuberculosis and current recommendations.
Kumar L
Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486
[No Abstract] [Full Text] [Related]
3. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Negi SS; Gupta S; Lal S
J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
[TBL] [Abstract][Full Text] [Related]
4. Cerebellar abscess and syringomyelia due to isoniazid-resistant Mycobacterium tuberculosis.
Ersoy Y; Ates O; Onal C; But AD; Cayli SR; Bayindir Y; Durmaz R
J Clin Neurosci; 2007 Jan; 14(1):86-9. PubMed ID: 17138074
[TBL] [Abstract][Full Text] [Related]
5. [Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens].
Aydın F; Kaklıkkaya N; Bayramoğlu G; Ozkul G; Buruk K; Dinç U; Köse T; Dede R
Mikrobiyol Bul; 2011 Jan; 45(1):36-42. PubMed ID: 21341157
[TBL] [Abstract][Full Text] [Related]
6. [Resistance rates to major anti-tuberculosis drugs in Mycobacterium tuberculosis strains isolated from seven different regions of Turkey in 2003-2006 period].
Uçar E; Kiliç A; Ceyhan I; Yilmaz S; Kiliç S; Tarhan G; Simşek H; Güllü U; Başustaoğlu AC
Mikrobiyol Bul; 2010 Jan; 44(1):11-9. PubMed ID: 20455394
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial resistance in tuberculosis].
Gutiérrez-Aroca JB; Ruiz P; Casal M
Rev Esp Quimioter; 2013 Dec; 26(4):332-6. PubMed ID: 24399346
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
Dickinson JM; Aber VR; Mitchison DA
Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
[TBL] [Abstract][Full Text] [Related]
10. Treatment of tuberculosis. The Mitchell lecture 1979.
Mitchison DA
J R Coll Physicians Lond; 1980 Apr; 14(2):91-5, 98-9. PubMed ID: 6767845
[No Abstract] [Full Text] [Related]
11. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
12. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
14. Drug-resistance of Mycobacterium tuberculosis in Patras, Greece.
Trakada G; Tsiamita M; Spiropoulos K
Monaldi Arch Chest Dis; 2004; 61(1):65-70. PubMed ID: 15366340
[TBL] [Abstract][Full Text] [Related]
15. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
Elghoul MT; Joshi RM; Rizghalla T
Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the BBL MGIT (Mycobacterial growth indicator tube) AST SIRE system for antimycobacterial susceptibility testing of Mycobacterium tuberculosis to 4 primary antituberculous drugs.
Bergmann JS; Fish G; Woods GL
Arch Pathol Lab Med; 2000 Jan; 124(1):82-6. PubMed ID: 10629136
[TBL] [Abstract][Full Text] [Related]
17. Isoniazid-Resistant Rifampicin-Susceptible Tuberculosis in Children.
Morales Pérez C; Gomez-Pastrana D; Aragón Fernández C; Pérez Escolano E
Arch Bronconeumol (Engl Ed); 2019 Jul; 55(7):388-390. PubMed ID: 30635203
[No Abstract] [Full Text] [Related]
18. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
19. [The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey].
Güneri S; Unsal I; Oztop A; Erkut M; Avkan Oğuz V; Ozgü A; Cakmak R
Mikrobiyol Bul; 2004 Jul; 38(3):203-12. PubMed ID: 15490839
[TBL] [Abstract][Full Text] [Related]
20. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
